SARS-CoV-2 vaccines for all but a single dose for COVID-19 survivors

Matthew Frieman; Anthony D. Harris; Ramin Sedaghat Herati; Florian Krammer; Alberto Mantovani; Maria Rescigno; Mohammad M. Sajadi; Viviana Simon

doi:10.1016/j.ebiom.2021.103401

SARS-CoV-2 vaccines for all but a single dose for COVID-19 survivors

Matthew Frieman, Anthony D. Harris, Ramin Sedaghat Herati, Florian Krammer, Alberto Mantovani, Maria Rescigno, Mohammad M. Sajadi, Viviana Simon

Research output: Contribution to journal › Comment/debate

39 Scopus citations

Original language	English
Article number	103401
Journal	eBioMedicine
Volume	68
DOIs	https://doi.org/10.1016/j.ebiom.2021.103401
State	Published - Jun 2021

Access to Document

10.1016/j.ebiom.2021.103401

Cite this

@article{a355c727dd1048b182f7296564e78452,

title = "SARS-CoV-2 vaccines for all but a single dose for COVID-19 survivors",

author = "Matthew Frieman and Harris, {Anthony D.} and Herati, {Ramin Sedaghat} and Florian Krammer and Alberto Mantovani and Maria Rescigno and Sajadi, {Mohammad M.} and Viviana Simon",

note = "Funding Information: The work of the Krammer and Simon laboratories is partially funded by the NIAID Collaborative Influenza Vaccine Innovation Centers (CIVIC) contract 75N93019C00051, NIAID Center of Excellence for Influenza Research and Surveillance (CEIRS, contract # HHSN272201400008C and HHSN272201400006C), by the generous support of the JPB Foundation and the Open Philanthropy Project (research grant 2020-215611 (5384); and by anonymous donors.",

year = "2021",

month = jun,

doi = "10.1016/j.ebiom.2021.103401",

language = "English",

volume = "68",

journal = "eBioMedicine",

issn = "2352-3964",

publisher = "Elsevier BV",

}

TY - JOUR

T1 - SARS-CoV-2 vaccines for all but a single dose for COVID-19 survivors

AU - Frieman, Matthew

AU - Harris, Anthony D.

AU - Herati, Ramin Sedaghat

AU - Krammer, Florian

AU - Mantovani, Alberto

AU - Rescigno, Maria

AU - Sajadi, Mohammad M.

AU - Simon, Viviana

N1 - Funding Information: The work of the Krammer and Simon laboratories is partially funded by the NIAID Collaborative Influenza Vaccine Innovation Centers (CIVIC) contract 75N93019C00051, NIAID Center of Excellence for Influenza Research and Surveillance (CEIRS, contract # HHSN272201400008C and HHSN272201400006C), by the generous support of the JPB Foundation and the Open Philanthropy Project (research grant 2020-215611 (5384); and by anonymous donors.

PY - 2021/6

Y1 - 2021/6

UR - http://www.scopus.com/inward/record.url?scp=85106925852&partnerID=8YFLogxK

U2 - 10.1016/j.ebiom.2021.103401

DO - 10.1016/j.ebiom.2021.103401

M3 - Comment/debate

C2 - 34051441

AN - SCOPUS:85106925852

SN - 2352-3964

VL - 68

JO - eBioMedicine

JF - eBioMedicine

M1 - 103401

ER -